Achaogen Quick Ratio (AKAO) starting from the fourth quarter 2018 to fourth quarter 2017, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Achaogen, Inc.  (AKAO)

Achaogen's Quick Ratio

AKAO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2018, Quick Ratio fell to 0.71 a new company low.

Within Major Pharmaceutical Preparations industry 294 other companies have achieved higher Quick Ratio than Achaogen in fourth quarter 2018. While Quick Ratio total ranking in the fourth quarter 2018 has deteriorated compared to the prior quarter from 954 to 2177.

Explain Quick Ratio?
How much Cash & cash equivalents AKAO´s has?
What are AKAO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKAO Quick Ratio (Dec 31 2018)
Q4		 (Sep 30 2018)
Q3		 (Jun 30 2018)
Q2		 (Mar 31 2018)
Q1		 (Dec 31 2017)
Q4
Y / Y Current Liabilities Change 102.4 % -12.93 % 3.82 % -9.21 % 86.34 %
Y / Y Cash & cash equivalent Change -83.77 % -71.68 % -55.58 % 14.24 % 136.08 %
Quick Ratio MRQ 0.71 2.21 3.45 6.54 8.89
AKAO's Total Ranking # 2177 # 954 # 686 # 448 # 677
Seq. Current Liabilities Change 195.45 % -13.74 % 33.42 % -40.47 % 27.1 %
Seq. Cash & cash equivalent Change -4.43 % -44.91 % -29.61 % -56.19 % 66.69 %



Quick Ratio fourth quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 295
Healthcare Sector # 652
Overall Market # 2177


Quick Ratio Statistics
High Average Low
14.41 6.29 0.71
(Jun 30 2014)   (Dec 31 2018)




Financial Statements
Achaogen's Current Liabilities $ 78 Millions Visit AKAO's Balance sheet
Achaogen's Cash & cash equivalent $ 56 Millions Visit AKAO's Balance sheet
Source of AKAO's Sales Visit AKAO's Sales by Geography


Cumulative Achaogen's Quick Ratio

AKAO's Quick Ratio for the trailling 12 Months

AKAO Quick Ratio

 (Dec 31 2018)
12 Months		 (Sep 30 2018)
12 Months		 (Jun 30 2018)
12 Months		 (Mar 31 2018)
12 Months		 (Dec 31 2017)
12 Months
Y / Y Current Liabilities TTM Growth 27.79 % 12.04 % 22.07 % 34.63 % 59.52 %
Y / Y Cash & cash equivalent TTM Growth -59.72 % -8.8 % 39.76 % 129.97 % 182.38 %
Quick Ratio TTM 2.34 5.54 6.57 7.72 7.42
Total Ranking TTM # 4734 # 494 # 297 # 297 # 100
Seq. Current Liabilities TTM Growth 33.31 % -3.2 % 0.93 % -1.88 % 16.89 %
Seq. Cash & cash equivalent TTM Growth -43.71 % -18.33 % -14.12 % 2.04 % 27.43 %

Quick ratio ranking by company, industry and sector >> Back to AKAO Financial Strength Comparisons >> Go to Compare AKAO Quick Ratio to its Competitors

On the trailing twelve months basis Due to in Current Liabilities in the Q4 2018 to $78.45 millions, cumulative Quick Ratio decreased to 2.34 below the Achaogen, Inc. average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 424 other companies have achieved higher Quick Ratio than Achaogen. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2018 from 494 to 4734.

Explain Quick Ratio?
How much Cash & cash equivalents AKAO´s has?
What are AKAO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 425
Healthcare Sector # 826
Within the Market # 4734


trailing twelve months Quick Ratio Statistics
High Average Low
10.06 5.63 0.62
(Mar 31 2015)   (Mar 31 2014)




Companies with similar Quick Ratio in the quarter ending Dec 31 2018, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2018 MRQ Cash & cash equivalentDec 31 2018 MRQ Current Liabilities
Prophase Labs Inc   1.95 $ 8.241  Millions$ 4.233  Millions
Avedro Inc  1.94 $ 9.769  Millions$ 5.037  Millions
Sio Gene Therapies Inc   1.88 $ 84.939  Millions$ 45.205  Millions
Bristol myers Squibb Company  1.88 $ 10,534.000  Millions$ 5,610.000  Millions
Aptevo Therapeutics Inc   1.87 $ 30.635  Millions$ 16.365  Millions
Moleculin Biotech Inc   1.84 $ 7.134  Millions$ 3.878  Millions
Zevra Therapeutics Inc   1.81 $ 21.669  Millions$ 12.004  Millions
Spectrum Pharmaceuticals Inc   1.78 $ 203.988  Millions$ 114.422  Millions
Cocrystal Pharma Inc   1.77 $ 2.763  Millions$ 1.557  Millions
Tg Therapeutics Inc   1.77 $ 68.806  Millions$ 38.854  Millions
Scisparc Ltd  1.76 $ 1.485  Millions$ 0.844  Millions
Vbi Vaccines Inc  1.75 $ 59.270  Millions$ 33.869  Millions
Catalyst Pharmaceuticals Inc   1.74 $ 16.559  Millions$ 9.511  Millions
Protokinetix Incorporated  1.72 $ 0.136  Millions$ 0.079  Millions
Checkpoint Therapeutics inc   1.68 $ 21.995  Millions$ 13.093  Millions
Chembio Diagnostics Inc   1.67 $ 12.525  Millions$ 7.495  Millions
Dmk Pharmaceuticals Corporation  1.67 $ 19.272  Millions$ 11.554  Millions
Omeros Corporation  1.62 $ 60.498  Millions$ 37.356  Millions
Biomarin Pharmaceutical Inc  1.62 $ 1,084.308  Millions$ 670.686  Millions
Alkermes Plc   1.60 $ 539.295  Millions$ 336.605  Millions
Inhibitor Therapeutics Inc   1.58 $ 1.109  Millions$ 0.701  Millions
Mereo Biopharma Group Plc  1.55 $ 38.697  Millions$ 24.950  Millions
Akebia Therapeutics Inc   1.54 $ 321.640  Millions$ 208.713  Millions
Cns Pharmaceuticals Inc   1.51 $ 0.283  Millions$ 0.187  Millions
Theratechnologies Inc   1.51 $ 38.997  Millions$ 25.830  Millions
Fortress Biotech Inc   1.49 $ 83.112  Millions$ 55.614  Millions
Chiasma Inc   1.46 $ 41.662  Millions$ 28.627  Millions
Medicure Inc   1.43 $ 18.491  Millions$ 12.970  Millions
Elite Pharmaceuticals Inc   1.42 $ 7.261  Millions$ 5.115  Millions
Ptc Therapeutics inc   1.36 $ 227.586  Millions$ 166.796  Millions

Date modified: 2026-09-18T14:07:35+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.